Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Gene Editing
18 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Regulatory
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
PR-M03-22-03
Gene Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Gene Editing
Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent
PAO-07-21-CL-06
Cell and Gene Therapy
6 Analytical Strategies to Consider Before Submitting Your Cell and Gene Therapy Application
PAO-06-21-CL-04
Collaboration
Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing
PR-M04-21-024
Gene Editing
Enhancing Human Gut Tissue Models through Gene Editing
PAO-11-20-CL-03
CRISPR RNPs
CRISPR RNPs and the Future of Cell and Gene Therapy
PAP-Q3-20-CL-002
Gene Therapy
Slow Progress and a Shaky Start—What’s Next for Gene Therapy?
PAP-Q4-19-NI-001
CRISPR-Cas9
CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
PAP-Q4-19-CL-011
Gene Editing
Trucode Launched to Advance Next-Generation Gene Editing Platform
PR-M09-19-NI-027
CRISPR
CRISPR Gene Editing of Babies Could Take Place in Russia
PAO-M06-19-NI-021
Gene Editing
China to Introduce Regulations on Gene Editing
PAO-M05-19-NI-031
CRISPR-Cas9
University of California Granted New CRISPR-Cas9 Patent, Extending its Patent Portfolio for Genome Editing
PR-M03-19-NI-040
Cell and Gene Therapy
Precision BioSciences Aims for Significant Funding Support based on its ARCUS Gene Editing Tech
PAO-M03-19-NI-013
Genome Editing
Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913
PR-M02-19-NI-020
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
Gene Editing
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
PAO-M11-17-NI-046
Gene Editing
More Gene Editing Technology Being Developed by Novartis
PAO-M11-17-NI-043
